Generex Biotechnology Corporation
GNBTQ
OTC PK
| 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | 04/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -40.89% | -67.37% | 3.86% | -- | -- |
| Total Depreciation and Amortization | 108.81% | 122.09% | 70.13% | -- | -- |
| Total Amortization of Deferred Charges | -72.44% | -70.38% | -51.35% | -- | -- |
| Total Other Non-Cash Items | -50.71% | 369.39% | -21.05% | -- | -- |
| Change in Net Operating Assets | 269.71% | 152.49% | 65.74% | -- | -- |
| Cash from Operations | 66.13% | 62.62% | 49.21% | -- | -- |
| Capital Expenditure | 100.00% | 100.00% | 99.93% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -100.00% | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -100.00% | -100.02% | -- | -- |
| Total Debt Issued | -67.31% | -84.96% | -59.35% | -- | -- |
| Total Debt Repaid | -147.18% | 86.65% | 93.92% | -- | -- |
| Issuance of Common Stock | 3,439.07% | 2,809.11% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.65% | -27.45% | -- | -- | -- |
| Cash from Financing | -38.72% | -43.99% | -25.22% | -- | -- |
| Foreign Exchange rate Adjustments | -13.33% | -271.88% | -345.16% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 226.96% | 115.54% | 116.08% | -- | -- |
